The ‘Back Side’ of Compartments | Saye Khoo, MD, PhD

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

Will we see the Back of DDIs? | Catia Marzolini, PharmD, PhD

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

Pharmacogenetics - Back to reality | Andrew Owen, BSS, MSC, PhD, FSB

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

Looking Backwards: Hormonal Contraception and ART | Kimberly Scarsi, PharmD, MS, FCCP

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

Janssen - Rilpivirine | Herta Crauwels, PhD

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

Target Concentrations | Angela Kashuba, PharmD

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

The FDA Perspective on Hepatitis C Drug Resistance | Patrick Harrington, PHD

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

Other Viruses: using Wolbachia to interrupt transmission of viral infections such as Dengue, Chikungunya and Zika | Steven Kern, PhD

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

Update on COVID-19 Therapeutics - Daniel Kuritzkes, MD

COVID-19 Clinical Forum 2021

COVID-19 Vaccine Safety Short- and Long- Term - Karine Lacombe, MD, PhD

COVID-19 Clinical Forum 2021

The Post-Acute Sequelae of SARS-CoV-2 (PASC) - Carlos del Rio, MD

COVID-19 Clinical Forum 2021

Update on COVID-19 Therapeutics - D. Kuritzkes, MD

COVID-19 Clinical Forum 2021

The Post-Acute Sequelae of SARS-CoV-2 (PASC) - C. del Rio, MD

COVID-19 Clinical Forum 2021

COVID-19 Vaccine Safety Short- and Long- Term - K. Lacombe, MD, PhD

COVID-19 Clinical Forum 2021

Acute Hepatitis C Infection | Christoph Boesecke, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

State of the Art Treatment of Hepatitis B | Maria Buti, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Epidemiology of Hepatitis B in Central and Eastern Europe | Adrian Streinu Cercel, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Management of Drug Drug Interactions | David Back, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

An Integrated Approach to HCV Treatment in People who Inject Drugs Cross Europe | Mojca Maticic, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

State of the Art Treatment of HCV | Sanjay Bhagani, BSc FRCP

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Management of End-stage Liver Disease | Massimo Puoti, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Natural History of HCV Infection | Krzysztof Simon, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Local Situation in Turkey | Cihan Yurdaydin, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Local Situation in Czech and Slovak Republics | Viktor Aster, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015